|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 401/04 | |
| C07D 413/04 | |||
| A61P 27/00 |
| (11) | Number of the document | 3033332 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14753140.4 |
| Date of filing the European patent application | 2014-08-14 | |
| (97) | Date of publication of the European application | 2016-06-22 |
| (45) | Date of publication and mention of the grant of the patent | 2018-09-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/GB2014/052511 |
| Date | 2014-08-14 |
| (87) | Number | WO 2015/022547 |
| Date | 2015-02-19 |
| (30) | Number | Date | Country code |
| 201314578 | 2013-08-14 | GB | |
| 201361865696 P | 2013-08-14 | US |
| (72) |
EDWARDS, Hannah Joy, GB
EVANS, David Michael, GB
DAVIE, Rebecca Louise, GB
ROOKER, David Philip, GB
HEWISON, Steven John, GB
|
| (73) |
Kalvista Pharmaceuticals Limited,
Porton Science Park Bybrook Road, Porton Down Wiltshire SP4 0BF,
GB
|
| (54) | BICYCLIC PLASMA KALLIKREIN INHIBITORS |
| BICYCLIC PLASMA KALLIKREIN INHIBITORS |